Understanding anticancer drug resistance: Opportunities for modulation and impact on new drug design

This publication has 35 references indexed in Scilit:

• Staurosporine, a potent inhibitor of C-kinase, enhances drug accumulation in multidrug-resistant cells
  Biochemical and Biophysical Research Communications, 1990
• Restorative effects of calmodulin antagonists on reduced cisplatin uptake by cisplatin-resistant human ovarian cancer cells
  Gynecologic Oncology, 1990
• Synergistic Effect of Cyclosporin A and Verapamil in Overcoming Vincristine Resistance of Multidrug‐resistant Cultured Human Leukemia Cells
  Japanese Journal of Cancer Research, 1990
• Overexpression of P-glycoprotein in Mammalian Tumor Cell Lines After Fractionated X Irradiation In Vitro
  JNCI Journal of the National Cancer Institute, 1990
• Design of NDA Intercalators To Overcome Topoisomerase II-Mediated Multidurg Resistance
  JNCI Journal of the National Cancer Institute, 1990
• Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma
  New England Journal of Medicine, 1990
• 9-Alkyl, morpholinyl anthracyclines in the circumvention of multidrug resistance
  European Journal of Cancer and Clinical Oncology, 1990
• INTENSIVE TREATMENT OF MULTIPLE MYELOMA AND CRITERIA FOR COMPLETE REMISSION
  The Lancet, 1989
• Importance of the DNA repair enzyme O6-alkyl guanine alkyltransferase (AT) in cancer chemotherapy
  Cancer Treatment Reviews, 1988
• METHOTREXATE SYSTEMIC CLEARANCE INFLUENCES PROBABILITY OF RELAPSE IN CHILDREN WITH STANDARD-RISK ACUTE LYMPHOCYTIC LEUKAEMIA
  The Lancet, 1984